Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NasdaqGS - Delayed Quote USD

Fortrea Holdings Inc. (FTRE)

Compare
13.85
-0.20
(-1.42%)
At close: February 28 at 4:00:02 PM EST
13.85
-0.00
(-0.00%)
After hours: February 28 at 6:19:11 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Thomas H. Pike CEO & Chairman 2.19M -- 1959
Ms. Jill McConnell Chief Financial Officer 735.39k -- 1975
Mr. Mark A. Morais COO & President of Clinical Services 732.47k -- 1977
Mr. Drayton Virkler President & Chief Commercial Officer -- -- --
Mr. Robert Parks Chief Accounting Officer -- -- --
Dr. John J. Doyle M.D. Chief Scientific Officer & President of Consulting Services -- -- --
Mr. Alejandro Martinez Galindo Chief Information Officer -- -- --
Mr. Dave Cooper Chief Administrative Officer -- -- --
Ms. Hima B. Inguva Head of Investor Relations & Corporate Development -- -- --
Mr. J. Stillman Hanson J.D. General Counsel & Corporate Secretary -- -- --

Fortrea Holdings Inc.

8 Moore Drive
Durham, NC 27709
United States
877 495 0816 https://www.fortrea.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
15,500

Description

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Corporate Governance

Fortrea Holdings Inc.’s ISS Governance QualityScore as of March 1, 2025 is 7. The pillar scores are Audit: 10; Board: 7; Shareholder Rights: 5; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 3, 2025 at 1:30 PM UTC

Fortrea Holdings Inc. Earnings Date

Recent Events

February 21, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 8, 2024 at 1:00 PM UTC

Q3 2024 Earnings Call

November 8, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 26, 2024 at 12:00 AM UTC

8-K/A: Corporate Changes & Voting Matters

August 12, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 11, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 20, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 7, 2024 at 12:00 AM UTC

8-K/A: Corporate Changes & Voting Matters

June 4, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 28, 2024 at 12:00 AM UTC

SC 13D/A: Tender Offer/Acquisition Reports

Related Tickers